John Morton, professor and vice chair, quality division chief of bariatric and minimally invasive surgery at the Yale School of Medicine, said seeing the burden of the cost shift from the insurer to the patient is disturbing
Current data shows that a significant percentage of the population does not meet their daily requirement for several nutrients, and this may be exacerbated by a drastic reduction in calorie intake because of the use of GLP-1 medications, he says
Because of this, BPC-157 is generally approached as an emerging option, and medical guidance is essential when considering it
While their efficacy in promoting weight loss is well-documented, understanding the potential side effects and their implications for patients is crucial for making informed treatment options
Gorman, GS, Chinnery, PF, DiMauro, S, Hirano, M, Koga, Y, McFarland, R, Suomalainen, A, Thorburn, DR, Zeviani, M, Turnbull, DM 2016, Mitochondrial diseases, Nature Reviews Disease Primers , vol
What Is BPC-157 and Why Are Miami Patients Asking for It